https://sputnikglobe.com/20220615/russias-gamaleya-centre-assesses-sputnik-vs-effectiveness-against-omicron-1096339497.html
Boosted Sputnik V Maintains 97% Effectiveness Against Omicron, Study Shows
Boosted Sputnik V Maintains 97% Effectiveness Against Omicron, Study Shows
Sputnik International
The study showed that the vaccine is 97% effective when boosted with Sputnik Light or revaccinated with Sputnik V in cases of hospitalisation from the COVID-19... 15.06.2022, Sputnik International
2022-06-15T12:08+0000
2022-06-15T12:08+0000
2022-06-15T12:13+0000
russia
covid-19
sputnik v vaccine
gamaleya research institute of epidemiology and microbiology
omicron strain
https://cdn1.img.sputnikglobe.com/img/07e6/04/1e/1095173552_0:114:3193:1910_1920x0_80_0_0_fabaaed0bf3de3ea0c431bb944fd5715.jpg
A team of Russian scientists, including specialists from the Vorokhobov City Clinical Hospital No. 67 and the Gamaleya National Centre of Epidemiology and Microbiology, have carried out research into the effectiveness of the Sputnik V vaccine against the Omicron variant.Effectiveness against all types of hospital admission after receiving at least one dose of the vaccine was 85.9%, the study detailed.The original Sputnik V (Gam-COVID-Vac), developed by Russia's Gamaleya Research Institute, was registered in August 2020 and has since been authorised for use in 71 countries with a total population of over 4 billion people. The two-dose vaccine has a single-dose version - Sputnik Light - which has been authorised in more than 30 countries. The Russian Direct Investment Fund invested in the development and production of the Sputnik V and Sputnik Light vaccines.
https://sputnikglobe.com/20220525/sputnik-v-offers-stronger-protection-against-omicron-than-pfizer-spallanzani-institute-study-shows-1095761440.html
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2022
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
covid-19, sputnik v vaccine, gamaleya research institute of epidemiology and microbiology, omicron strain
covid-19, sputnik v vaccine, gamaleya research institute of epidemiology and microbiology, omicron strain
Boosted Sputnik V Maintains 97% Effectiveness Against Omicron, Study Shows
12:08 GMT 15.06.2022 (Updated: 12:13 GMT 15.06.2022) The study showed that the vaccine is 97% effective when boosted with Sputnik Light or revaccinated with Sputnik V in cases of hospitalisation from the COVID-19 strain.
A team of Russian scientists, including specialists from the Vorokhobov City Clinical Hospital No. 67 and the Gamaleya National Centre of Epidemiology and Microbiology,
have carried out research into the effectiveness of the Sputnik V vaccine
against the Omicron variant.
“According to the results, the efficacy of the Sputnik V vaccine boosted with Sputnik Light or revaccinated with Sputnik V was 97% against all types of hospital admissions caused by the Omicron strain and 99.4% against critical cases”, the study showed.
Effectiveness against all types of hospital admission after receiving at least one dose of the vaccine was 85.9%, the study detailed.
The original Sputnik V (Gam-COVID-Vac), developed by Russia's Gamaleya Research Institute, was registered in August 2020 and has since been authorised for use in 71 countries with a total population of over 4 billion people. The two-dose vaccine has a single-dose version - Sputnik Light - which has been authorised in more than 30 countries. The Russian Direct Investment Fund invested in the development and production of the Sputnik V and Sputnik Light vaccines.
